ClinConnect ClinConnect Logo
Search / Trial NCT03370211

Resistance Training and Sarcopenic Obesity Elderly Women

Launched by UNIVERSIDADE ESTADUAL DE LONDRINA · Dec 6, 2017

Trial Information

Current as of August 30, 2025

Completed

Keywords

Resistance Training Inflammatory Markers Functional Capacity

ClinConnect Summary

To investigate the effects of resistance training (RT) program on body composition, functional capacity, inflammatory and oxidative stress biomarkers in sarcopenic obesity elderly women. This study is a randomized controlled trial. Thirty-seven sarcopenic obesity (SO) elderly women were randomly allocated into two groups: a training group (TG, n=18) or a non-exercising control group (CG, n=19). A supervised RT program was performed by TG for 12 weeks and CG did not perform any type of physical exercise during this period. Body composition (DXA), functional capacity \[(muscular strength, and...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 60 years old or more;
  • presented sarcopenic obesity SO \[which was defined by the simultaneous presence of sarcopenia and obesity (Batsis et al., 2015; Studenski et al., 2014), whereas women were considered sarcopenic if appendicular lean soft tissue (LST) \<15.02 kg, and obese if percentage of body fat ≥ 35% (Batsis et al., 2015)\];
  • physically independent;
  • free from cardiac or orthopedic dysfunction;
  • not receiving hormonal replacement and/or thyroid therapy;
  • not using equipment that would compromise the accomplishment of protocols and tests;
  • not performing any regular physical exercise more than once a week over the six months preceding the beginning of the investigation.
  • Exclusion Criteria:
  • individuals with any metallic implant or artificial pacemaker, who had undergone surgery, who were unable to perform the tests and trainings;
  • volunteers who failed the medical examination for any reason;
  • refused or were unable to give consent.

About Universidade Estadual De Londrina

The Universidade Estadual de Londrina (UEL) is a reputable academic institution located in Brazil, renowned for its commitment to advancing research and education in the health sciences. As a clinical trial sponsor, UEL leverages its extensive expertise and resources to conduct innovative research aimed at improving patient outcomes and contributing to medical knowledge. The university fosters collaboration among multidisciplinary teams, ensuring rigorous adherence to ethical standards and regulatory guidelines. UEL's dedication to scientific excellence and community health positions it as a pivotal player in the landscape of clinical research.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials